WCG Wealth Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.63M Buy
76,536
+8,756
+13% +$839K 0.19% 122
2025
Q4
$6.51M Buy
67,780
+40,683
+150% +$3.95M 0.18% 124
2025
Q3
$2.58M Sell
27,097
-2,378
-8% -$219K 0.16% 125
2025
Q2
$2.57M Buy
29,475
+1,861
+7% +$158K 0.17% 132
2025
Q1
$2.48M Sell
27,614
-770
-3% -$68.9K 0.19% 129
2024
Q4
$2.27M Buy
28,384
+5,606
+25% +$485K 0.15% 142
2024
Q3
$2.05M Sell
22,778
-596
-3% -$50.1K 0.14% 154
2024
Q2
$1.84M Buy
23,374
+2,706
+13% +$222K 0.14% 144
2024
Q1
$1.8M Buy
20,668
+3,738
+22% +$319K 0.15% 131
2023
Q4
$1.4M Buy
+16,930
New +$1.29M 0.1% 171

Other funds holding MDT

WCG Wealth Advisors's MDT Position: Q1 2026 in Review

WCG Wealth Advisors increased its Medtronic (MDT) stake by 13% in Q1 2026, buying an estimated $839K and bringing the position to 76,536 shares worth $6.63M. The position accounts for 0.19% of the portfolio, ranked #122.

WCG Wealth Advisors first reported a position in MDT in Q4 2023 and has held it in 10 quarters since. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • WCG Wealth Advisors held 76,536 shares of Medtronic worth $6.63M as of Q1 2026.
  • WCG Wealth Advisors bought 8,756 Medtronic shares in Q1 2026, an estimated $839K.
  • Medtronic made up 0.19% of WCG Wealth Advisors's portfolio in Q1 2026, its #122 holding.
  • WCG Wealth Advisors first reported a position in Medtronic in Q4 2023 and has held it in 10 quarters since.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on WCG Wealth Advisors's 13F filing for Q1 2026, filed 12 May 2026.